Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prochymal in moderate-to-severe Crohn's disease
NCT00294112Phase 2Completed
- Sponsor
- Mesoblast Ltd
- Start
- Mar 2006
- Primary completion
- Jul 2006
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of remestemcel-L-rknd in Crohn's disease, sponsored by Mesoblast Ltd. Started Mar 2006; status: completed.
02
Drugs
remestemcel-L-rknd
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT00294112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00294112.